Critical analysis of Chagas disease treatment in different countries

de Souza Nogueira Sardinha Mendes, Fernanda; Perez-Molina, Jose Antonio; Angheben, Andrea; Meymandi, Sheba; Sosa-Estani, Sergio; Molina Romero, Israel

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	de Souza Nogueira Sardinha Mendes, Fernanda
dc.contributor.author	Perez-Molina, Jose Antonio
dc.contributor.author	Angheben, Andrea
dc.contributor.author	Meymandi, Sheba
dc.contributor.author	Sosa-Estani, Sergio
dc.contributor.author	Molina Romero, Israel
dc.date.accessioned	2022-09-15T06:50:55Z
dc.date.available	2022-09-15T06:50:55Z
dc.date.issued	2022-07-08
dc.identifier.citation	de Souza Nogueira Sardinha Mendes F, Perez-Molina JA, Angheben A, Meymandi SK, Sosa-Estani S, Molina I. Critical analysis of Chagas disease treatment in different countries. Mem Inst Oswaldo Cruz. 2022 Jul 8;117:e210034.
dc.identifier.issn	1678-8060
dc.identifier.uri	https://hdl.handle.net/11351/8193
dc.description	Chagas disease; Treatment; Benznidazole
dc.description.abstract	As a result of globalization and constant migratory flows, Chagas disease is now present in almost all continents. The management and treatment of the disease is often influenced by the economic and social context of the societies that host patients. In this manuscript, we aim to provide a comparative review of approaches to patients with Chagas disease in the Americas and Europe.
dc.language.iso	eng
dc.publisher	Fundação Oswaldo Cruz
dc.relation.ispartofseries	Memórias do Instituto Oswaldo Cruz;117
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Chagas, Malaltia de - Tractament
dc.subject	Europa
dc.subject	Malalties - Presa de decisions
dc.subject.mesh	Chagas Disease
dc.subject.mesh	/drug therapy
dc.subject.mesh	Disease Management
dc.subject.mesh	Europe
dc.title	Critical analysis of Chagas disease treatment in different countries
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1590/0074-02760210034
dc.subject.decs	enfermedad de Chagas
dc.subject.decs	/farmacoterapia
dc.subject.decs	tratamiento de las enfermedades
dc.subject.decs	Europa (continente)
dc.relation.publishversion	https://doi.org/10.1590/0074-02760210034
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[de Souza Nogueira Sardinha Mendes F] Fundação Oswaldo Cruz-Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, RJ, Brasil. [Perez-Molina JA] Ramón y Cajal University Hospital, Instituto Ramón y Cajal de Investigación Sanitaria, Infectious Diseases Department, National Referral Unit for Tropical Diseases, Madrid, Spain. [Angheben A] Istituto di Ricovero e Cura a Carattere Scientifico Sacro Cuore Don Calabria Hospital Department of Infectious - Tropical Diseases and Microbiology, Negrar di Valpolicella, Verona, Italy. [Meymandi SK] University of California, Center of Excellence for Chagas Disease at Olive View, Los Angeles, CA, US. [Sosa-Estani S] Drugs for Neglected Diseases initiative, Rio de Janeiro, RJ, Brasil. National Scientific and Technical Research Council, Epidemiology and Public Health Research Center, Buenos Aires, Argentina. [Molina I] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Programa de Salut Internacional de l’Institut Català de la Salut, Barcelona, Spain. Fundação Oswaldo Cruz-Fiocruz, Instituto René Rachou, Laboratório de Triatomíneos e Epidemiologia da Doença de Chagas, Belo Horizonte, MG, Brasil
dc.identifier.pmid	35830002
dc.identifier.wos	000826471500001
dc.rights.accessrights	info:eu-repo/semantics/openAccess